Cipla

Price chart

Previous close

₹1,405.80

Open

₹1,409.90

Day high

₹1,421.40

Day low

₹1,402.50

Listed on NSE since 8 February 1995.

Futures and options

Futures, 23 Nov expiry

₹1,409.90

Premium to the share price

+5.70 (+0.41%)

Futures open interest

22,175 contracts (−64 today)

Lot size (NOV 26)

425 shares

Source: NSE, 09-Nov-2026 12:03:49, delayed. Option chain · All futures · Lot sizes

Pivot levels

R3

1,449.67

R2

1,430.33

R1

1,420.67

CPR top

1,406.17

Pivot

1,401.33

CPR bottom

1,396.50

S1

1,391.67

S2

1,372.33

S3

1,362.67

From Friday 6 November’s high, low and close (Yahoo Finance). Arithmetic on past prices, not a forecast.

Market value

₹1,13,573 Cr

P/E (trailing)

39.22

EPS (trailing)

₹35.84

Price to book

3.21

Dividend yield

0.92%

Return on equity

8.3%

Debt to equity

0.02

Profit margin

10.4%

Beta

0.10

Volume today

6.76 L

Average volume

9.95 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Cipla’s results filed with NSE, consolidated (the whole group). Net profit is the share of Cipla’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Cipla’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Mumbai

Employees

31,369

Company website · Profile: Yahoo Finance

• Cipla Share Price Live Updates: Cipla's Price Movement Signals Caution

  The Economic Times · 9 Nov, 08:30

• Dividend - Rs 13 Per Share

  Dividend · ex-date 5 June 2026

• Dividend - Rs 13 Per Share/Special Dividend - Rs 3 Per Share

  Dividend · ex-date 27 June 2025

• Dividend - Rs 13 Per Share

  Dividend · ex-date 2 August 2024

• Dividend - Rs 8.50 Per Share

  Dividend · ex-date 21 July 2023

• Dividend - Rs 5 Per Share

  Dividend · ex-date 8 August 2022 · record date 10 August 2022

• Annual General Meeting/Dividend - Rs 5 Per Share

  Dividend · ex-date 9 August 2021

• Annual General Meeting

  Action · ex-date 11 August 2020

• Interim Dividend - Rs 3 Per Share Special Dividend - Re 1 Per Share

  Dividend · ex-date 19 March 2020 · record date 20 March 2020

Source: NSE. Latest first, 8 of 20.